Publications by authors named "Edward Rowe"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

524,327

Total Likes

14,438

Extended Reach

4,075,348

Social Features

195
T
The Prostate cancer-Exercise and Metformin randomised controlled feasibility Trial (Pre-EMpT) in men following active surveillance, radical prostatectomy and radiotherapy.
Luke A Robles, Lucy McGeagh, Jonathan Aning, Amit Bahl, Amarnath Challapalli, Edward Rowe

Pilot Feasibility Stud· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease.
Rachel M Barker, Alfie Chambers, Patrick G Kehoe, Edward Rowe, Claire M Perks

Clin Sci (Lond)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National audit of patient reported experience of radical cystectomy for bladder cancer pathways.
Preksha Kuppanda, Louisa Hermans, Alan Uren, Nikki Cotterill, Edward Rowe

BJUI Compass· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer.
Rachel Barker, Kalina Biernacka, Georgina Kingshott, Alex Sewell, Paida Gwiti, Edward Rowe

Growth Horm IGF Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
Jenny L Donovan, Freddie C Hamdy, J Athene Lane, Grace J Young, Chris Metcalfe, Edward Rowe

NEJM Evid· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of cardiopulmonary exercise testing (CPET) and Charlson comorbidity index (CCI) in a large contemporary cohort of patients undergoing robot-assisted radical cystectomy and intracorporeal urinary diversion (RARC-ICUD).
Arthur McPhee, Alexander Ridgway, Thomas Bird, Raj Pal, Edward W Rowe

BJUI Compass· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.
Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Edward Rowe

Oncotarget· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
Janet Athene Lane, Jenny L Donovan, Grace J Young, Michael Davis, Eleanor I Walsh, Edward Rowe

BJU Int· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer-Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer.
Lucy McGeagh, Luke A Robles, Raj Persad, Edward Rowe, Amit Bahl

Pilot Feasibility Stud· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of the Cystectomy-Pathway Assessment Tool (C-PAT): a concise tool to assess the quality of care in the cystectomy pathway.
Alan D Uren, Nikki Cotterill, Paul Abrams, James W F Catto, Biral Patel, Edward Rowe

BJU Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.
James W F Catto, Pramit Khetrapal, Federico Ricciardi, Gareth Ambler, Norman R Williams, Edward Rowe

JAMA· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitudes and adherence to changes in nutrition and physical activity following surgery for prostate cancer: a qualitative study.
Luke A Robles, Ellie Shingler, Lucy McGeagh, Edward Rowe, Anthony Koupparis

BMJ Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder.
Amarnath Challapalli, Susan Masson, Paul White, Narges Dailami, Sylvia Pearson, Edward Rowe

Clin Genitourin Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes.
Wei Shen Tan, Rajan Arianayagam, Pramit Khetrapal, Edward Rowe, Samantha Kearley

Eur Urol Open Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer.
Georgina Kingshott, Kalina Biernacka, Alex Sewell, Paida Gwiti, Rachel Barker, Edward Rowe

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].
David E Neal, Chris Metcalfe, Jenny L Donovan, J Athene Lane, Michael Davis, Edward Rowe

Eur Urol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer.
Sian M Noble, Kirsty Garfield, J Athene Lane, Chris Metcalfe, Michael Davis, Edward Rowe

Br J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial.
Julia Wade, Jenny Donovan, Athene Lane, Michael Davis, Eleanor Walsh, Edward Rowe

BMJ Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Freddie C Hamdy, Jenny L Donovan, J Athene Lane, Malcolm Mason, Chris Metcalfe, Edward Rowe

Health Technol Assess· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.
Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Edward Rowe

Oncotarget· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
David E Neal, Chris Metcalfe, Jenny L Donovan, J Athene Lane, Michael Davis, Edward Rowe

Eur Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells.
Zhen Tang, David Gillatt, Edward Rowe, Anthony Koupparis, Jeff M P Holly

Oncotarget· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer.
Lucy E Hackshaw-McGeagh, Chris Penfold, Ellie Shingler, Luke A Robles, Claire M Perks, Edward Rowe

BMJ Open· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis.
Martha M C Elwenspoek, Athena L Sheppard, Matthew D F McInnes, Samuel W D Merriel, Edward W J Rowe

JAMA Netw Open· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis